NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Bolt Biotherapeutics, Inc. (“Bolt” or the “Company”) (NASDAQ: BOLT) and certain officers. The class action, filed in the United States District Court for the Northern…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.